PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.77%
Negative revenue growth while BIDU stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-3.43%
Negative gross profit growth while BIDU is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
7.49%
EBIT growth of 7.49% while BIDU is zero. Bruce Berkowitz would see if small gains can be scaled further.
7.49%
Operating income growth of 7.49% while BIDU is zero. Bruce Berkowitz would see if this modest edge can become significant.
14.38%
Net income growth of 14.38% while BIDU is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
15.06%
Positive EPS growth while BIDU is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
15.24%
Diluted EPS growth above 1.5x BIDU's 0.14%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.58%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.60%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
52.51%
Positive OCF growth while BIDU is negative. John Neff would see this as a clear operational advantage vs. the competitor.
113.22%
Positive FCF growth while BIDU is negative. John Neff would see a strong competitive edge in net cash generation.
465.41%
10Y revenue/share CAGR above 1.5x BIDU's 267.88%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
147.88%
5Y revenue/share CAGR above 1.5x BIDU's 44.54%. David Dodd would look for consistent product or market expansions fueling outperformance.
57.77%
3Y revenue/share CAGR above 1.5x BIDU's 19.27%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
611.84%
10Y OCF/share CAGR above 1.5x BIDU's 72.11%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
169.11%
5Y OCF/share CAGR at 50-75% of BIDU's 273.58%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
62.20%
3Y OCF/share CAGR 1.25-1.5x BIDU's 45.05%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
642.70%
Net income/share CAGR above 1.5x BIDU's 2.47% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
297.90%
Below 50% of BIDU's 892.91%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
43.12%
Positive short-term CAGR while BIDU is negative. John Neff would see a clear advantage in near-term profit trajectory.
245.98%
Below 50% of BIDU's 516.05%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
78.67%
5Y equity/share CAGR above 1.5x BIDU's 51.02%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
38.08%
3Y equity/share CAGR above 1.5x BIDU's 3.61%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.11%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
1.23%
Asset growth at 50-75% of BIDU's 1.95%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
3.95%
BV/share growth above 1.5x BIDU's 2.25%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.45%
We’re deleveraging while BIDU stands at 5.68%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-6.59%
Our R&D shrinks while BIDU invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-30.55%
We cut SG&A while BIDU invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.